
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down
The Danish pharmaceutical company, which competes heavily with Indianapolis-based Eli Lilly and Co. in the weight-loss market, is leaving by “mutual agreement” with the company’s board of directors.